Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline in the Class Action Lawsuit Against American Oriental Bioeng...
26 7월 2012 - 8:54AM
Business Wire
Law Offices of Howard G. Smith announces that all purchasers of
the securities of American Oriental Bioengineering, Inc. (“AOBI” or
the “Company”) (OTC:AOBI) between November 9, 2009 and June 15,
2012, inclusive (the “Class Period”), have until August 22, 2012 to
move the Court to serve as Lead Plaintiff in the securities fraud
class action lawsuit filed in the United States District Court for
the Central District of California.
AOBI engages in the development, manufacture and
commercialization of pharmaceutical and healthcare products. The
Complaint alleges that the defendants made false and misleading
statements and/or failed to disclose material adverse facts about
AOBI’s operations and financial performance. Specifically,
defendants misrepresented and/or failed to disclose that: (1)
certain of the Company’s capsule products maintained chrome levels
far exceeding humanly tolerable limits; (2) the Company’s financial
statements contained material inconsistencies; (3) the Company’s
internal controls over financial reporting were deficient; and (4),
as a result of the foregoing, the Company’s statements were
materially false and misleading at all relevant times.
No class has yet been certified in the above action. Until a
class is certified, you are not represented by counsel unless you
retain one. If you purchased AOBI securities between November 9,
2009 and June 15, 2012, you have certain rights, and have until
August 22, 2012 to move for lead plaintiff status. To be a member
of the class you need not take any action at this time, or may
retain counsel of your choice. If you wish to discuss this action
or have questions concerning this Notice or your rights or
interests with respect to these matters, please contact Howard G.
Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol
Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at
215-638-4847, Toll-Free at 888-638-4847, or by email to
howardsmith@howardsmithlaw.com, or visit our website at
http://www.howardsmithlaw.com.
American Oriental Bioeng... (CE) (USOTC:AOBI)
과거 데이터 주식 차트
부터 10월(10) 2024 으로 11월(11) 2024
American Oriental Bioeng... (CE) (USOTC:AOBI)
과거 데이터 주식 차트
부터 11월(11) 2023 으로 11월(11) 2024
American Oriental Bioengineering Inc (CE) (OTC 시장)의 실시간 뉴스: 최근 기사 0
More Law Offices of Howard G. Smith News Articles